Literature DB >> 10545391

Potassium current suppression in patients with peripheral nerve hyperexcitability.

T Nagado1, K Arimura, Y Sonoda, A Kurono, Y Horikiri, A Kameyama, M Kameyama, O Pongs, M Osame.   

Abstract

Acquired neuromyotonia (Isaac's syndrome) is considered to be an autoimmune disease, and the pathomechanism of nerve hyperexcitability in this syndrome is correlated with anti-voltage-gated K(+) channel (VGKC) antibodies. The patch-clamp technique was used to investigate the effects of immunoglobulins from acquired neuromyotonia patients on VGKCs and voltage-gated Na(+) channels in a human neuroblastoma cell line (NB-1). K(+) currents were suppressed in cells that had been co-cultured with acquired neuromyotonia patients' immunoglobulin for 3 days but not for 1 day. The activation and inactivation kinetics of the outward K(+) currents were not altered by these immunoglobulins, nor did the immunoglobulins significantly affect the Na(+) currents. Myokymia or myokymic discharges, with peripheral nerve hyperexcitability, also occur in various neurological disorders such as Guillain-Barré syndrome and idiopathic generalized myokymia without pseudomyotonia. Immuno-globulins from patients with these diseases suppressed K(+) but not Na(+) currents. In addition, in hKv 1.1- and 1.6-transfected CHO (Chinese hamster ovary)-K1 cells, the expressed VGKCs were suppressed by sera from acquired neuromyotonia patients without a change in gating kinetics. Our findings indicate that nerve hyperexcitability is mainly associated with the suppression of voltage-gated K(+) currents with no change in gating kinetics, and that this suppression occurs not only in acquired neuromyotonia but also in Guillain-Barré syndrome and idiopathic generalized myokymia without pseudomyotonia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545391     DOI: 10.1093/brain/122.11.2057

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

1.  A 45-year history of acquired autoimmune neuromyotonia.

Authors:  Aisling Ryan; Gerard Mullins; Jacqui Scott; Sean Connolly; Orla Hardiman; Emrullah Yilmaz; Angela Vincent; Tim Lynch
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

2.  A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance.

Authors:  Michele Basso; Alessandra Cassano; Anna Modoni; Daniele Spada; Nunziatina Trigila; Michela Quirino; Giovanni Schinzari; Carlo Barone
Journal:  Eur J Clin Pharmacol       Date:  2008-03-19       Impact factor: 2.953

3.  A possible mechanism of repetitive firing of myelinated axon.

Authors:  Alexander G Dimitrov
Journal:  Pflugers Arch       Date:  2009-02-10       Impact factor: 3.657

4.  Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome.

Authors:  Carlo Rinaldi; Cinzia Valeria Russo; Alessandro Filla; Giuseppe De Michele; Enrico Marano
Journal:  Neurol Sci       Date:  2009-03-04       Impact factor: 3.307

5.  Stroke preceding autoimmune encephalitis with neuronal potassium channel antibody.

Authors:  Patricia Simal; Ana Maria Garcia-García; Carmen Serna-Candel; Jose Antonio Egido
Journal:  BMJ Case Rep       Date:  2012-05-08

6.  Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.

Authors:  K Dedek; B Kunath; C Kananura; U Reuner; T J Jentsch; O K Steinlein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

7.  Continuum simulations of acetylcholine diffusion with reaction-determined boundaries in neuromuscular junction models.

Authors:  Yuhui Cheng; Jason K Suen; Zoran Radić; Stephen D Bond; Michael J Holst; J Andrew McCammon
Journal:  Biophys Chem       Date:  2007-01-19       Impact factor: 2.352

8.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.

Authors:  Sarosh R Irani; Sian Alexander; Patrick Waters; Kleopas A Kleopa; Philippa Pettingill; Luigi Zuliani; Elior Peles; Camilla Buckley; Bethan Lang; Angela Vincent
Journal:  Brain       Date:  2010-07-27       Impact factor: 13.501

9.  Autoimmune channelopathies of the nervous system.

Authors:  Kleopas A Kleopa
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

Review 10.  Autoimmune synaptopathies.

Authors:  Sarah J Crisp; Dimitri M Kullmann; Angela Vincent
Journal:  Nat Rev Neurosci       Date:  2016-02       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.